Overview
Stephen Ryan was chosen to accompany the CEO of pharmaceuticals company Mylan N.V., to a House Oversight and Government Reform Committee hearing that will examine the company’s pricing of its EpiPen product. Mr. Ryan was the company’s outside counsel in previous communication with the Senate Judiciary Committee about the price of EpiPen.